Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting

Drug Delivery

Volumn 21, Issue 2, 2014, Pages 148-154

  Mahajan, Hitendra S ^a   Mahajan, Milind S ^a   Nerkar, Pankaj P ^a   Agrawal, Anshuman ^b  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^b Shri Siddhivinayak Ganapati Cancer Hospital   (India)

Author keywords

CNS targeting; Intranasal delivery; Nanoemulsion; Neuro AIDS; Saquinavir mesylate

Indexed keywords

SAQUINAVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG TARGETING; GAMMA SCINTIGRAPHY; IN VIVO STUDY; MALE; NANOEMULSION; NONHUMAN; NOSE MUCOSA; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SHEEP; ZETA POTENTIAL;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DRUG DELIVERY SYSTEMS; EMULSIONS; MALE; NANOPARTICLES; NASAL MUCOSA; RATS; RATS, SPRAGUE-DAWLEY; SAQUINAVIR; SHEEP;

EID: 84896877099     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.838014     Document Type: Article

References (23)

1. Bali V, Ali M, Ali J. (2010). Study of surfactant combinations and development of a novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. Coll Surf B: Biointer 76:410-20.
2. Chow HHS, Chen Z, Matsuura GT. (1999). Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats. J Pharm Sci 88:754-8.
3. Danielyan L, Schafer R, Von Ameln-Mayerhofer A, et al. (2009). Intranasal delivery of cells to the brain. Eur J Cell Biol 88:315-24.
4. Danielyan L, Schafer R, Von Ameln-Mayerhofer A, et al. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 14:3-16.
5. Hanson LR, Frey II WH. (2007). Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune Pharm 2:81-6.
6. Hanson LR, Roeytenberg A, Martinez PM, et al. (2009). Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther 330:679-86.
7. Illum L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 56:3-17.
8. Jiang XG, Cui JB, Fang XL, et al. (1995). Toxicity of drugs on nasal mucocilia and the method of its evaluation. Acta Pharmacol Sin 30: 848-53.
9. Kaul M. (2008). HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci 13:2484-94.
10. Kiechel Jean-Rene, Acezat-Mispelter Francoise, Plas Danielle. (1989). United States Patent 4,885,305.
11. Liang WQ, Fang XL, Gao S, et al. (2003). Biopharmaceutics and pharmacokinetics, 2nd ed. Beijing: People's Medical Publishing House, 37.
12. Mahajan HS, Gattani SG. (2010). In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Del 17:19-27.
13. Mistry A, Stolnik S, Illum L. (2009). Nanoparticles for direct noseto-brain delivery of drugs. Int J Pharm 379:146-57.
14. Mudigonda K, Jukanti R, Apte, SS, et al. (2006). HPLC quantification of the HIV-1 protease inhibitor saquinavir in brain and testis of mice. Biomed Chromatogr 20:1028-32.
15. Nicolas A, Thierry FV. (2009). The universality of low-energy nanoemulsification. Int J Pharm 377:142-7.
16. Nottet HS, Persidsky Y, Sasseville VG. (1996). Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156:1284-95.
17. Parveen R, Baboota S, Ali J, et al. (2011). Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm 413:245-53.
18. Sarker DK. (2005). Engineering of nanoemulsions for drug delivery. Curr Drug Del 2:297-310.
19. Strazielle N, Ghersi-Egea JF. (2005). Factors affecting delivery of antiviral drugs to the brain. Rev Med Virol 15:105-33.
20. Thorne RG, Frey II WH. (2001). Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinetic 40:907-46.
21. Yang JP, Liu HJ, Cheng SM, et al. (2009). Direct transport of VEGF from the nasal cavity to brain. Neurosci Lett 449:108-11.
22. Zhang H, Yao M, Morrison RA, Chong, S. (2003). Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res 26:768-72.
23. Zhang Q, Jiang X, Jiang W, et al. (2004). Preparation of nimodipineloaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 275:85-96.